-
4041“…In summary, the JF-305 cell line was sensitive to olaparib and provided a prospective model for the preclinical assessment of PARP inhibitors in the therapy of pancreatic cancer.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4042“…Quantification of the association between the intake of cholesterol and risk of pancreatic cancer is still conflicting. We therefore conducted a meta-analysis to summarize the evidence from epidemiological studies of cholesterol intake and the risk of pancreatic cancer. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4043por Morifuji, Yoshihiro, Onishi, Hideya, Iwasaki, Hironori, Imaizumi, Akira, Nakano, Kenji, Tanaka, Masao, Katano, MitsuoEnlace del recurso
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4044“…OBJECTIVES: Although type 2 diabetes mellitus is a known risk factor for pancreatic cancer, the existence of shared genetic susceptibility is largely unknown. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4045por Taniuchi, Keisuke, Furihata, Mutsuo, Hanazaki, Kazuhiro, Iwasaki, Shinji, Tanaka, Kenjiro, Shimizu, Takahiro, Saito, Motoaki, Saibara, ToshijiEnlace del recurso
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4046por SOMASAGARA, RANGANATHA R., DEEP, GAGAN, SHROTRIYA, SANGEETA, PATEL, MANISHA, AGARWAL, CHAPLA, AGARWAL, RAJESH“…Pancreatic cancer (PanC) is one of the most lethal malignancies, and resistance towards gemcitabine, the front-line chemotherapy, is the main cause for dismal rate of survival in PanC patients; overcoming this resistance remains a major challenge to treat this deadly malignancy. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4047por Suzuki, Shuhei, Okada, Masashi, Shibuya, Keita, Seino, Manabu, Sato, Atsushi, Takeda, Hiroyuki, Seino, Shizuka, Yoshioka, Takashi, Kitanaka, Chifumi“…Chemoresistance associated with cancer stem cells (CSCs), which is now being held responsible for the pervasive therapy resistance of pancreatic cancer, poses a major challenge to the successful management of this devastating malignancy. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4048por Nishiwada, Satoshi, Sho, Masayuki, Yasuda, Satoshi, Shimada, Keiji, Yamato, Ichiro, Akahori, Takahiro, Kinoshita, Shoichi, Nagai, Minako, Konishi, Noboru, Nakajima, Yoshiyuki“…CONCLUSION: Nectin-4 is a significant prognostic predictor, and may play a critical role in pancreatic cancer. Nectin-4 may be novel therapeutic target for pancreatic cancer.…”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4049por Xue, Zhan-Xiong, Zheng, Ji-Hang, Zheng, Zhi-Qiang, Cai, Jing-Li, Ye, Xiao-Hua, Wang, Cheng, Sun, Wei-Jian, Zhou, Xiang, Lu, Ming-Dong, Li, Pi-Hong, Cai, Zhen-Zhai“…BACKGROUND: An increasing number of evidence suggests that pancreatic cancer contains cancer stem cells (CSCs), which may be relevant to the resistance of chemotherapy. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4050por Aravindan, Sheeja, Ramraj, Satish Kumar, Somasundaram, Somasundaram T, Aravindan, Natarajan“…BACKGROUND: Identifying the drug-deliverables that target autophagy is crucial to finding a cure for pancreatic cancer (PC), as activated autophagy is associated with poor patient outcomes. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4051por Komura, Takuya, Sakai, Yoshio, Harada, Kenichi, Kawaguchi, Kazunori, Takabatake, Hisashi, Kitagawa, Hirohisa, Wada, Takashi, Honda, Masao, Ohta, Tetsuo, Nakanuma, Yasuni, Kaneko, ShuichiEnlace del recurso
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4052por Nomura, Alice, Banerjee, Sulagna, Chugh, Rohit, Dudeja, Vikas, Yamamoto, Masato, Vickers, Selwyn M., Saluja, Ashok K.“…CD133 has been implicated as a cancer stem cell (CSC) surface marker in several malignancies including pancreatic cancer. However, the functional role of this surface glycoprotein in the cancer stem cell remains elusive. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4053The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migrationpor Cheng, Yating, Jutooru, Indira, Chadalapaka, Gayathri, Corton, J. Christopher, Safe, Stephen“…HOTTIP is expressed in pancreatic cancer cell lines and knockdown of HOTTIP by RNA interference (siHOTTIP) in Panc1 pancreatic cancer cells decreased proliferation, induced apoptosis and decreased migration. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4054por McGlynn, Liane M., McCluney, Simon, Jamieson, Nigel B., Thomson, Jackie, MacDonald, Alasdair I., Oien, Karin, Dickson, Euan J., Carter, C. Ross, McKay, Colin J., Shiels, Paul G.“…Information regarding the function of sirtuins in pancreatic cancer is sparse and equivocal. We undertook a novel study investigating SIRT1-7 protein expression in a cohort of pancreatic tumours. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4055por Song, Shanshan, Wang, Baosheng, Zhang, Xin, Hao, Liliang, Hu, Xianliang, Li, Zhongxiang, Sun, Shaolong“…PURPOSE: Previous studies have shown a bidirectional relationship between diabetes and pancreatic cancer (PC). In particular, new-onset diabetes might be induced by PC, and people with long-term diabetes might be at increased risk for the development of PC. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4056por Lohse, I, Borgida, A, Cao, P, Cheung, M, Pintilie, M, Bianco, T, Holter, S, Ibrahimov, E, Kumareswaran, R, Bristow, R G, Tsao, M-S, Gallinger, S, Hedley, D W“…BACKGROUND: Germline mutations of the BRCA tumour suppressors have been associated with increased risk of pancreatic cancer. Clinical evidence suggests that these patients may be more sensitive to treatment with cisplatin. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4057por Xu, Qinhong, Li, Pei, Chen, Xin, Zong, Liang, Jiang, Zhengdong, Nan, Ligang, Lei, Jianjun, Duan, Wanxing, Zhang, Dong, Li, Xuqi, Sha, Huanchen, Wu, Zheng, Ma, Qingyong, Wang, Zheng“…MicroRNAs are involved in the initiation and progression of pancreatic cancer. In this study, we showed that miR-221/222 is overexpressed in pancreatic cancer. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4058por Bai, Xueli, Zhang, Qi, Wu, Song, Zhang, Xiaoyu, Wang, Mingbang, He, Fusheng, Wei, Tao, Yang, Jiaqi, Lou, Yu, Cai, Zhiming, Liang, Tingbo“…Pancreatic cancer has a poor prognosis and few effective treatments. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4059“…Due to devastating prognosis, novel therapies are needed for pancreatic cancer. We are in preparation for a human clinical trial of a conditionally replicative adenovirus (CRAd) we developed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4060por Dhani, N C, Serra, S, Pintilie, M, Schwock, J, Xu, J, Gallinger, S, Hill, R P, Hedley, D W“…BACKGROUND: Hypoxia is thought to be an adverse feature of pancreatic cancer, but direct measurement in patients is technically challenging. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto